A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Acid With 0.3% Lidocain Hydrochloride, Prevelle Silk, for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines

NCT01267149 · clinicaltrials.gov ↗
UNKNOWN
Status
13
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Goldman, Butterwick, Fitzpatrick and Groff

Collaborators